Selidji Todagbe Agnandji

ORCID, self-asserted

ORCID 0000-0003-4693-4207

Publications

Citations

109

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

6 works in the graph, newest first.

Duration and association with protection of NANP-repeat-specific and C-terminus-specific anti-circumsporozoite protein IgG responses following RTS,S/AS01E vaccination: an observational ancillary immunological study of a phase 3 clinical trial
2026The Lancet Infectious DiseasesJournalOpen access2 citations10.1016/s1473-3099(26)00081-2
The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial
2024The Lancet Infectious DiseasesJournalOpen access10 citations10.1016/s1473-3099(24)00527-9
Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria
2023BMC Infectious DiseasesJournalOpen access8 citations10.1186/s12879-023-08699-7
Prostration and the prognosis of death in African children with severe malaria
2023International Journal of Infectious DiseasesJournalOpen accessFirst author3 citations10.1016/j.ijid.2023.06.022
Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection
2022JCI InsightJournalOpen access17 citations10.1172/jci.insight.158030
Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon
2022The Journal of Infectious DiseasesJournalOpen access14 citations10.1093/infdis/jiac322